Original Articles
Copyright ©The Author(s) 2000.
World J Gastroenterol. Jun 15, 2000; 6(3): 330-334
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.330
Figure 1
Figure 1 SDS-PAGE of Zot binding proteins isolated by affinity column chromatography from human brain cortex plasma membrane preparations. Lane 1, molecular mass standards; Lane 2, whole-plasma membrane lysate; lane 3, eluate with 0.5 mol·L-1 NaCl in PBS containing 1 g·L-1 Triton X-100.
Figure 2
Figure 2 Western immunoblotting of Zot and tau using either anti-Zot antibodies (left panel) or anti-tau antibodies (right panel). Zot and tau were recognized by both antibodies.
Figure 3
Figure 3 Microtubule binding assay. BSA (negative control) and MAP2 (positive control) were visualized by Coomassie staning (left panel) while Zot was visualized by immunoblotting (right panel). The bottom protein bands in the left panel are tubulins. As anticipated, BSA remained in the supernatant (S), while MAP2 was entirely precipitated in the pellet (P). Zot also appeared confined in the pellet, confirming that it bound to MT.